Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer

Fig. 2

the features of variants detected by cfDNA liquid biopsy. A barplot showing the proportion of each type of mutation detected by liquid biopsy. B Mutation signature of all variants detected in liquid biopsy. C Barplot showing the number of mutations detected in each sample. D Oncoprint plot showing all variants detected in each gene and sample

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us